Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Fabio Chianelli
Recent news which mentions Fabio Chianelli
Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder
November 01, 2022
Tickers
PHRRF
Tags
Cannabis
Ketamine Treatment
Fabio Chianelli
From
Benzinga
Ketamine for Parkinson's Disease, PharmaTher Holdings Announces Grant of U.S. Patent To Cover It
October 05, 2022
Tickers
PHRRF
Tags
FDA
PHRRF
Market News
From
Benzinga
PharmaTher Provides Business Highlights And Releases Audited Annual Financials
September 29, 2022
Tickers
PHRRF
Tags
Ketamine
Psychedelics
Earnings
From
Benzinga
PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease
September 17, 2022
Tickers
PHRRF
Tags
Penny Stocks
Markets
Parkinson’s Disease
From
Benzinga
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
September 07, 2022
Tickers
PHRRF
Tags
Benzinga
Psychedelics
Market News
From
Benzinga
PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson's And Motor Disorders Treatment
July 13, 2022
Tickers
PHRRF
Tags
Fabio Chianelli
Cannabis
Benzinga
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
LVTTF
AWKNF
Penny Stocks
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.